Loading...
Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore
Glioblastoma (GBM) is the most common primary malignant tumor of the central nervous system with a dismal prognosis. Locoregional failure is common despite high doses of radiation therapy, which has prompted great interest in developing novel strategies to radiosensitize these cancers. Our group pre...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8092340/ https://ncbi.nlm.nih.gov/pubmed/33953843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27933 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|